Apath, LLC

A path to scientific discovery.....

General Information
Company Name
Apath, LLC
Founded Year
1996
Location (Offices)
New York, United States
Founders / Decision Makers
Number of Employees
4
Industries
Biotechnology, Pharmaceutical
Funding Stage
-
Social Media

Apath, LLC - Company Profile

Apath, LLC is a privately held technology licensing company founded in 1996 by Dr. Charles M. Rice, Nobel Laureate in Medicine 2020. The company specializes in the commercial application of virology and viral genetics to aid pharmaceutical companies in discovering and developing therapeutic products for treating viral infections. Apath holds the fundamental intellectual property required for developing HCV and RSV Therapeutics, Antibodies, Vaccines, and SARS-CoV-2-related therapeutics. The company represents multiple academic institutions and commercial entities and is a premier technology licensing company for research and development tools used to validate therapies for various viruses, including the hepatitis C virus, respiratory syncytial virus, Ebola virus, sindbus virus, West Nile virus, influenza, and SARS-CoV-2. Apath operates in the Biotechnology and Pharmaceutical industries.

Name: Apath, LLC

Slogan: A path to scientific discovery

Description: Apath is a privately held technology licensing company founded by Dr. Charles M. Rice, Nobel Laureate in Medicine 2020, engaged in the commercial application of virology and viral genetics to assist pharmaceutical companies in discovering and developing therapeutic products for the treatment of viral infections.

Founded: 1996

Industries: Biotechnology, Pharmaceutical

As of now, there is no publicly available information about the company's headquarter, last investment, or the last investment's investors.

Taxonomy: Virology, Viral Genetics, Technology Licensing, Therapeutic Products, Hepatitis C Virus (HCV), Respiratory Syncytial Virus (RSV), Antiviral Research, Molecular Virology, Hemorrhagic Fever Viruses, Antibody Development, Vaccine Development, SARS-CoV-2 Therapeutics, Commercial Application, Drug Development, Academic/Commercial Collaboration

Funding Rounds & Investors of Apath, LLC (0)

View All

There is no investment information

Latest News of Apath, LLC

View All

No recent news or press coverage available for Apath, LLC.

Similar Companies to Apath, LLC

View All
Zalgen - Similar company to Apath, LLC
Zalgen Global Innovations. Solutions for all.
Advaccine - Similar company to Apath, LLC
Advaccine Advancing Vaccines,Improving Immunotherapeutics
Advaccine - Similar company to Apath, LLC
Advaccine Advancing Vaccines,Improving Immunotherapeutics
Oragenics, Inc - Similar company to Apath, LLC
Oragenics, Inc Our mission is focused on developing vaccines to prevent and treat today’s and tomorrow’s infections.
RetroVirox Inc. - Similar company to Apath, LLC
RetroVirox Inc. The Virology CRO serving all your antiviral needs